Hugel Inc.

Hugel Inc. is a biopharmaceutical company known for its specialization in the development and commercialization of botulinum toxin-related products and other aesthetic medicine solutions. Leveraging its expertise in biotechnology, Hugel is committed to innovating in the field of cosmetic and functional therapies. The company's primary focus is on treatments for aesthetic and medical issues such as wrinkles, muscular disorders, and excessive sweating. Hugel Inc. significantly influences the healthcare and cosmetics sectors by offering an array of injectables, fillers, and cosmeceutical products. Headquartered in South Korea, the company's operations extend globally, highlighting its strategic market presence in both Asian and international arenas. Hugel stands as a prominent player in the industry, dedicated to enhancing quality of life through advanced medical solutions and expanding its reach in the burgeoning market for aesthetic medicines.

CEO

문형진, 박철민 집행임원)

Employees

589

Website

hugel.co.kr